![Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology - Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology -](https://onlinelibrary.wiley.com/cms/asset/e34cc4b0-996a-4c89-8154-7af47ccf2e7f/jdv13305-fig-0005-m.jpg)
Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology -
![Rosabril Gel 30gm, schedule: H, , BRIMONIDINE, , , Brinton Pharmaceuticals Ltd, GEL, , Glaucoma - NepalMedishop Rosabril Gel 30gm, schedule: H, , BRIMONIDINE, , , Brinton Pharmaceuticals Ltd, GEL, , Glaucoma - NepalMedishop](https://nepmed.s3.ap-southeast-1.amazonaws.com/products/600x600/82368/rosabril_gel_30gm_0_0.jpg)
Rosabril Gel 30gm, schedule: H, , BRIMONIDINE, , , Brinton Pharmaceuticals Ltd, GEL, , Glaucoma - NepalMedishop
![These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL.BRIMONIDINE topical gelInitial U.S. Approval: 1996 These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL.BRIMONIDINE topical gelInitial U.S. Approval: 1996](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=carton-rev06-22.jpg&id=683221)